Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans

被引:99
作者
Lamon-Fava, S
Sadowski, JA
Davidson, KW
O'Brien, ME
McNamara, JR
Schaefer, EJ
机构
[1] Tufts Univ, USDA, Human Nutr Res Ctr Aging, Lipid Metab Lab, Boston, MA 02111 USA
[2] Tufts Univ, USDA, Human Nutr Res Ctr Aging, Vitamin K Lab, Boston, MA 02111 USA
关键词
phylloquinone; vitamin K; lipoproteins; triacylglycerol; absorption; clearance; humans;
D O I
10.1093/ajcn/67.6.1226
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The purpose of this study was to characterize the absorption and transport of phylloquinone (vitamin K-1) by plasma lipoproteins. Twenty-six healthy subjects (11 men and 15 women) aged 20-78 y received phylloquinone in the amount of either 1.43 or 50 mu g/kg body wt orally with a fat-rich meal containing 1.0 g/kg body wt of fat, carbohydrate, and protein and 7.0 mg cholesterol/kg body wt. Blood was obtained at baseline (0 h) and 3, 6, 9, and 12 h after the meal for the measurement of plasma lipid and phylloquinone concentrations in plasma and lipoprotein subfractions. In both groups of subjects, triacylglycerol concentrations peaked after 3 h in plasma and in the triacylglycerol-rich lipoprotein fraction, composed of chylomicrons and VLDLs. Plasma phylloquinone concentrations peaked at 6 h. At baseline and during the postprandial phase, > 53% of plasma phylloquinone was carried by the triacylglycerol-rich lipoprotein fraction. In 9 of the 11 subjects supplemented with 50 mu g phylloquinone/kg, plasma lipoproteins were isolated by sequential ultracentrifugation. In these subjects the fraction of plasma phylloquinone carried by LDLs and by HDLs increased progressively from 3% and 4% at 3 h to 14% and 11% at 12 h, respectively. Our data indicate that whereas triacylglycerol-rich lipoproteins are the major carriers of phylloquinone, LDL and HDL may carry small fractions of this vitamin.
引用
收藏
页码:1226 / 1231
页数:6
相关论文
共 33 条
  • [1] BLOMSTRAND R, 1968, INT Z VITAMINFORSCH, V38, P45
  • [2] Booth Sarah L., 1993, Journal of Food Composition and Analysis, V6, P109, DOI 10.1006/jfca.1993.1014
  • [3] BOVILL EG, 1994, SYSTEMIC CARDIAC EMB, P31
  • [4] Brown MS, 1991, CURR OPIN LIPIDOL, V2, P65
  • [5] COHN JS, 1988, J LIPID RES, V29, P925
  • [6] COHN JS, 1993, J LIPID RES, V34, P2033
  • [7] COHN JS, 1988, J LIPID RES, V29, P469
  • [8] EFFECT OF VITAMIN-E ON PROTHROMBIN LEVELS IN WARFARIN-INDUCED VITAMIN-K DEFICIENCY
    CORRIGAN, JJ
    ULFERS, LL
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (09) : 1701 - 1705
  • [9] FISHER KD, 1985, AM J CLIN NUTR, V42, P1318
  • [10] GIJSBERG BLM, 1966, BR J NUTR, V76, P223